Neither VEGF nor Ang2 serum levels showed a significant association with ECMO support in the clinical course of ARDS, but in the first days after initiation of ECMO support, VEGF serum levels declined significantly. The gene discussed is ANGPT2; the disease is acute respiratory distress syndrome.